These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 27900584)

  • 1. Low T Cell Numbers Resembling T-B+ SCID in a Patient with Wiskott-Aldrich Syndrome and the Outcome of Two Hematopoietic Stem Cell Transplantations.
    Cagdas D; Aytac S; Kuskonmaz B; Ariga T; van der Burg M; Cetinkaya DU; Sanal Ö; Tezcan İ
    J Clin Immunol; 2017 Jan; 37(1):18-21. PubMed ID: 27900584
    [No Abstract]   [Full Text] [Related]  

  • 2. Current and emerging treatment options for Wiskott-Aldrich syndrome.
    Worth AJ; Thrasher AJ
    Expert Rev Clin Immunol; 2015; 11(9):1015-32. PubMed ID: 26159751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. When
    Jin YY; Wu J; Chen TX; Chen J
    Front Immunol; 2019; 10():1549. PubMed ID: 31354712
    [No Abstract]   [Full Text] [Related]  

  • 4. B-cell reconstitution after lentiviral vector-mediated gene therapy in patients with Wiskott-Aldrich syndrome.
    Castiello MC; Scaramuzza S; Pala F; Ferrua F; Uva P; Brigida I; Sereni L; van der Burg M; Ottaviano G; Albert MH; Grazia Roncarolo M; Naldini L; Aiuti A; Villa A; Bosticardo M
    J Allergy Clin Immunol; 2015 Sep; 136(3):692-702.e2. PubMed ID: 25792466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The genotype of the original Wiskott phenotype.
    Binder V; Albert MH; Kabus M; Bertone M; Meindl A; Belohradsky BH
    N Engl J Med; 2006 Oct; 355(17):1790-3. PubMed ID: 17065640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal distribution of distinct lymphocyte subsets in children with Wiskott-Aldrich syndrome.
    Zhou L; Li W; Zhang X; Liu D; Ding Y; Dai R; Zhao X
    Hum Immunol; 2017 Sep; 78(9):565-573. PubMed ID: 28535968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wiskott-Aldrich syndrome: diagnosis, clinical and laboratory manifestations, and treatment.
    Ochs HD; Filipovich AH; Veys P; Cowan MJ; Kapoor N
    Biol Blood Marrow Transplant; 2009 Jan; 15(1 Suppl):84-90. PubMed ID: 19147084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wiskott-Aldrich syndrome; an x-linked primary immunodeficiency disease with unique and characteristic features.
    Ariga T
    Allergol Int; 2012 Jun; 61(2):183-9. PubMed ID: 22361515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Wiskott-Aldrich syndrome: recent progress in diagnosis and treatment].
    Nonoyama S
    Rinsho Ketsueki; 2009 Oct; 50(10):1570-6. PubMed ID: 19915368
    [No Abstract]   [Full Text] [Related]  

  • 10. Outcomes of hematopoietic stem cell transplantation in primary immunodeficiency: a report from the Australian and New Zealand Children's Haematology Oncology Group and the Australasian Bone Marrow Transplant Recipient Registry.
    Mitchell R; Nivison-Smith I; Anazodo A; Tiedemann K; Shaw P; Teague L; Fraser C; Carter T; Tapp H; Alvaro F; O'Brien TA
    Biol Blood Marrow Transplant; 2013 Mar; 19(3):338-43. PubMed ID: 23228588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of gene therapy for Wiskott-Aldrich syndrome using a WAS promoter/cDNA-containing lentiviral vector and nonlethal irradiation.
    Dupré L; Marangoni F; Scaramuzza S; Trifari S; Hernández RJ; Aiuti A; Naldini L; Roncarolo MG
    Hum Gene Ther; 2006 Mar; 17(3):303-13. PubMed ID: 16544979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stable mixed chimerism after hematopoietic stem cell transplantation in Wiskott-Aldrich syndrome.
    Doğu F; Kurtuluş-Ulküer M; Bilge Y; Bozdoğan G; Ulküer U; Malhatun E; Ikincioğullari A; Babacan E
    Pediatr Transplant; 2006 May; 10(3):395-9. PubMed ID: 16677369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wiskott-Aldrich syndrome.
    Notarangelo LD; Miao CH; Ochs HD
    Curr Opin Hematol; 2008 Jan; 15(1):30-6. PubMed ID: 18043243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Wiskott-Aldrich syndrome: description of a clinical case].
    De Bernardi A; Chessa Ricotti G; Galli L; Funis M
    Pediatr Med Chir; 1990; 12(6):691-3. PubMed ID: 2093894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early deficit of lymphocytes in Wiskott-Aldrich syndrome: possible role of WASP in human lymphocyte maturation.
    Park JY; Kob M; Prodeus AP; Rosen FS; Shcherbina A; Remold-O'Donnell E
    Clin Exp Immunol; 2004 Apr; 136(1):104-10. PubMed ID: 15030520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful renal transplantation in a patient with a Wiskott-Aldrich syndrome protein (WASP) gene mutation.
    Chovancova Z; Kuman M; Vlkova M; Litzman J
    Transpl Int; 2015 Aug; 28(8):1005-9. PubMed ID: 25864580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene therapy for Wiskott-Aldrich syndrome--long-term efficacy and genotoxicity.
    Braun CJ; Boztug K; Paruzynski A; Witzel M; Schwarzer A; Rothe M; Modlich U; Beier R; Göhring G; Steinemann D; Fronza R; Ball CR; Haemmerle R; Naundorf S; Kühlcke K; Rose M; Fraser C; Mathias L; Ferrari R; Abboud MR; Al-Herz W; Kondratenko I; Maródi L; Glimm H; Schlegelberger B; Schambach A; Albert MH; Schmidt M; von Kalle C; Klein C
    Sci Transl Med; 2014 Mar; 6(227):227ra33. PubMed ID: 24622513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytoreductive conditioning for severe combined immunodeficiency--help or hindrance?
    Laberko A; Gennery AR
    Expert Rev Clin Immunol; 2015; 11(7):785-8. PubMed ID: 26099343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined immune deficiencies in children.
    Kobrynski LJ
    J Infus Nurs; 2006; 29(4):206-13. PubMed ID: 16858253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allogeneic Transplant for Mycosis Fungoides in Patient with Wiskott-Aldrich Syndrome.
    Criscuolo M; Fianchi L; Chiusolo P; Giammarco S; Bacigalupo A; Pagano L
    J Clin Immunol; 2018 Jan; 38(1):7-9. PubMed ID: 29196934
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.